Compared to HF treatment alone, which reduced luminescence by approximately twofold (p < 0.05), proline supplementation restored luminescence, and therefore TGFβ‐SMAD signalling activity, to levels similar to controls (p < 0.05 compared to cells treated with HF). Here, TGFB1 is linked to hydrops fetalis.